Background.
Human immunodeficiency virus (HIV)–infected persons have an elevated risk for lung cancer, but whether the increase reflects solely their heavy tobacco use remains an open question.
Methods.
The Acquired Immunodeficiency Syndrome (AIDS) Link to the Intravenous Experience Study has prospectively observed a cohort of injection drug users in Baltimore, Maryland, since 1988, using biannual collection of clinical, laboratory, and behavioral data. Lung cancer deaths were identified through linkage with the National Death Index. Cox proportional hazards regression was used to examine the effect of HIV infection on lung cancer risk, controlling for smoking status, drug use, and clinical variables.
Results.
Among 2086 AIDS Link to the Intravenous Experience Study participants observed for 19,835 person‐years, 27 lung cancer deaths were identified; 14 of the deaths were among HIV‐infected persons. All but 1 (96%) of the patients with lung cancer were smokers, smoking a mean of 1.2 packs per day. Lung cancer mortality increased during the highly active antiretroviral therapy era, compared with the pre–highly active antiretroviral therapy period (mortality rate ratio, 4.7; 95% confidence interval, 1.7–16). After adjusting for age, sex, smoking status, and calendar period, HIV infection was associated with increased lung cancer risk (hazard ratio, 3.6; 95% confidence interval, 1.6–7.9). Preexisting lung disease, particularly noninfectious diseases and asthma, displayed trends for increased lung cancer risk. Illicit drug use was not associated with increased lung cancer risk. Among HIV‐infected persons, smoking remained the major risk factor; CD4 cell count and HIV load were not strongly associated with increased lung cancer risk, and trends for increased risk with use of highly active antiretroviral therapy were not significant.
Conclusions.
HIV infection is associated with significantly increased risk for developing lung cancer, independent of smoking status.
Cited by
Kristina Crothers, Joseph L. Goulet, Maria C. Rodriguez-Barradas, Cynthia L. Gibert, Kris Ann K. Oursler, Matthew Bidwell Goetz, Stephen Crystal, David A. Leaf, Adeel A. Butt, R. Scott Braithwaite, Robin Peck, Amy C. Justice. (2009) Impact of Cigarette Smoking on Mortality in HIV-Positive and HIV-Negative Veterans.
AIDS Education and Prevention 21:3_supplement, 40-53
Online publication date: 1-Jul-2009.
CrossRef Nancy R. Reynolds. (2009) Cigarette Smoking and HIV: More Evidence for Action.
AIDS Education and Prevention 21:3_supplement, 106-121
Online publication date: 1-Jul-2009.
CrossRef Damon J. Vidrine. (2009) Cigarette Smoking and HIV/AIDS: Health Implications, Smoker Characteristics and Cessation Strategies.
AIDS Education and Prevention 21:3_supplement, 3-13
Online publication date: 1-Jul-2009.
CrossRef Mariah M. Marshall, Meredith C. McCormack, Gregory D. Kirk. (2009) Effect of Cigarette Smoking on HIV Acquisition, Progression, and Mortality.
AIDS Education and Prevention 21:3_supplement, 28-39
Online publication date: 1-Jul-2009.
CrossRef Shadi Nahvi, Nina A. Cooperman. (2009) Review: The Need for Smoking Cessation Among HIV-Positive Smokers.
AIDS Education and Prevention 21:3_supplement, 14-27
Online publication date: 1-Jul-2009.
CrossRef Kelly A. Gebo, Amy Justice. (2009) HIV infection in the elderly.
Current Infectious Disease Reports 11:3, 246-254
Online publication date: 1-Jun-2009.
CrossRef Andrew E Grulich. (2009) Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Current Opinion in HIV and AIDS 4:3, 183-187
Online publication date: 1-Jun-2009.
CrossRef Kenneth A. Lichtenstein. (2009) Antiretroviral treatment interruptions and risk of non-opportunistic diseases.
Current HIV/AIDS Reports 6:2, 77-82
Online publication date: 1-Jun-2009.
CrossRef Caroline A Sabin, Andrew N Phillips. (2009) Should HIV therapy be started at a CD4 cell count above 350 cells/μl in asymptomatic HIV-1-infected patients?.
Current Opinion in Infectious Diseases 22:2, 191-197
Online publication date: 1-May-2009.
CrossRef Liron Pantanowitz, Bruce J Dezube. (2009) Evolving spectrum and incidence of non-AIDS-defining malignancies.
Current Opinion in HIV and AIDS 4:1, 27-34
Online publication date: 1-Feb-2009.
CrossRef Claire M. Vajdic, Marina T. van Leeuwen. (2009) Cancer incidence and risk factors after solid organ transplantation.
International Journal of Cancer NA-NA
Online publication date: 1-Feb-2009.
CrossRef Nancy Crum-Cianflone, Katherine Huppler Hullsiek, Vincent Marconi, Amy Weintrob, Anuradha Ganesan, R Vincent Barthel, Susan Fraser, Brian K Agan, Scott Wegner. (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
AIDS 23:1, 41-50
Online publication date: 1-Feb-2009.
CrossRef Kate Buchacz, Maria Rangel, Rachel Blacher, John T. Brooks. (2009) Changes in the clinical epidemiology of HIV infection in the United States: Implications for the clinician.
Current Infectious Disease Reports 11:1, 75-83
Online publication date: 1-Feb-2009.
CrossRef Claire M Vajdic, Marina T van Leeuwen. (2009) What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients.
Current Opinion in HIV and AIDS 4:1, 35-41
Online publication date: 1-Feb-2009.
CrossRef Michael J Silverberg, Donald I Abrams. (2009) Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?.
Current Opinion in HIV and AIDS 4:1, 42-51
Online publication date: 1-Feb-2009.
CrossRef Fabrice Bonnet, Geneviève Chêne. (2009) Evolving epidemiology of malignancies in HIV.
Current Opinion in Internal Medicine 7:6, 626-632
Online publication date: 1-Jan-2009.
CrossRef Andrew N Phillips, James Neaton, Jens D Lundgren. (2008) The role of HIV in serious diseases other than AIDS.
AIDS 22:18, 2409-2418
Online publication date: 1-Dec-2008.
CrossRef (2008) HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
AIDS 22:16, 2143-2153
Online publication date: 1-Nov-2008.
CrossRef Alexandra Bazoes, Mark Bower, Thomas Powles. (2008) Smoke and mirrors: HIV-related lung cancer.
Current Opinion in Oncology 20:5, 529-533
Online publication date: 1-Oct-2008.
CrossRef Fabrice Bonnet, Geneviève Chêne. (2008) Evolving epidemiology of malignancies in HIV.
Current Opinion in Oncology 20:5, 534-540
Online publication date: 1-Oct-2008.
CrossRef Charlotte Lewden, Thierry May, Eric Rosenthal, Christine Burty, Fabrice Bonnet, Dominique Costagliola, Eric Jougla, Caroline Semaille, Philippe Morlat, Dominique Salmon, Patrice Cacoub, Geneviève Chêne. (2008) Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic).
JAIDS Journal of Acquired Immune Deficiency Syndromes 48:5, 590-598
Online publication date: 1-Sep-2008.
CrossRef Roger Bedimo. (2008) Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.
Current HIV/AIDS Reports 5:3, 140-149
Online publication date: 1-Sep-2008.
CrossRef Eric A Engels. (2008) Inflammation in the development of lung cancer: epidemiological evidence.
Expert Review of Anticancer Therapy 8:4, 605-615
Online publication date: 1-May-2008.
CrossRef Raffaella Rosso, Antonio Biagio, Claudio Viscoli. (2008) Infectious complications of cancer chemotherapy in HIV patients.
Current Infectious Disease Reports 10:2, 149-156
Online publication date: 1-Apr-2008.
CrossRef Jessica L Long, Eric A Engels, Richard D Moore, Kelly A Gebo. (2008) Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
AIDS 22:4, 489-496
Online publication date: 1-Mar-2008.
CrossRef Kevin P. Cain and William R. Mac Kenzie. (2008)
Editorial Commentary: Overcoming the Limits of Tuberculosis Prevention among Foreign‐Born Individuals: Next Steps toward Eliminating Tuberculosis.
Clinical Infectious Diseases 46:1, 107-109
Online publication date: 1-Jan-2008.